Lv1
20 积分 2026-05-06 加入
Nanotechnology-based PD-L1 siRNA codelivery systems for improving cancer immunotherapy
4个月前
已完结
Nanocarrier-engineered therapeutics for Glioblastoma: Challenges and strategies for overcoming the blood-brain barrier
4个月前
已完结
An orally available non-nucleotide STING agonist with antitumor activity
4个月前
已完结
Bioengineering strategies to optimize STING agonist therapy
4个月前
已完结